Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Whole Exome Sequencing Market?
In the past few years, the whole exome sequencing market has expanded at a swift pace. Its value will increase from $2.82 billion in 2024 to $3.36 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 19.1%. The upward trajectory during the historic period can be linked to progress in genomic research, the rise of precision medicine, diagnosis of rare ailments, applications in pharmaceutical and biotech, and the fall in sequencing prices.
In the coming years, the overall size of the whole exome sequencing market is expected to experience significant growth. The market size is anticipated to reach $7.27 billion in 2029, with a compound annual growth rate (CAGR) of 21.3%. Several factors contributing to this projected growth include increased usage in oncology, incorporation in clinical diagnostics, a surge in the demand for genetic testing, the initiation of population genomics, and the rise of gene therapies. Key expected trends during this forecast period entail improved clinical use and adoption rates, a decrease in sequencing costs, emphasis on securing data privacy, integration with electronic health records, and progress in single-cell sequencing.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp
Which Market Dynamics Are Playing A Critical Role In The Growth Of The Whole Exome Sequencing Market?
The continuous rise in the prevalence of HIV (human immunodeficiency virus) is anticipated to drive the expansion of the whole exome sequencing market in the future. HIV is a virus that primarily attacks the body’s immune system. Whole exome sequencing is employed to discern the genomic structures of viruses, which are instrumental for personalized treatment and creating vaccines for HIV. As an example, the Minority HIV/AIDS Fund (MHAF), a US government agency, reported in August 2024 that in 2023, nearly 39.9 million people worldwide were HIV positive, including 38.6 million adults and 1.4 million children. This was an increase from preceding years. Consequently, the escalating prevalence of HIV is the main factor propelling the growth of the whole exome sequencing market.
What Are The Key Segment Trends Observed In The Whole Exome Sequencing Market?
The whole exome sequencingmarket covered in this report is segmented –
1) By Product: Systems; Kits; Services
2) By Technology: Sequencing By Synthesis; Ion Semiconductor Sequencing; Other Technologies
3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research
4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Academic and Research Institutes; Clinical Laboratories; Other End-Users
Subsegments:
1) By Systems: Sequencing Systems; Data Analysis Systems
2) By Kits: Library Preparation Kits; Exome Enrichment Kits; Sequencing Kits
3) By Services: Data Analysis Services; Consulting Services; Custom Sequencing Services
What Strategic Shifts And Innovations Are Influencing The Whole Exome Sequencing Market?
Emerging diagnostic advancements are a prevailing trend gaining traction in the whole exome sequencing market. Businesses in this industry are focusing on novel product development to maintain their market standing. For instance, Illumina Inc., an American biotechnology firm, released NovaSeqX Plus in February 2023. This is currently the most sophisticated technology for sequencing, blending high throughput with supreme accuracy. It is highlighted by simplified informatics, improved sustainability, and cost-efficient sequencing. The NovaSeq X Plus systems’ innovative features have the capability to generate tens of thousands of whole genomes annually, optimizing productivity and reducing processing times.
Who Are The Leading Companies Driving The Whole Exome Sequencing Market?
Major companies operating in the whole exome sequencing market include Thermo Fisher Scientific Inc., Illumina Inc., Eurofins Genomics, Azenta US Inc., CD Genomics, Psomagen Inc., Agilent Technologies, BGI Genomics, F. Hoffmann-La Roche Ltd., QIAGEN Inc., Macrogen Inc., Ambry Genetics, Bio-Rad Laboratories Inc., Bioneer Corporation, Foundation Medicine Inc., KONICA MINOLTA INC., Otogenetics Corporation, Geneyx Genomex Ltd., ArcherDX Inc., Blueprint Genetics Oy, Bionano Genomics Inc., Centogene AG, Fulgent Genetics Inc., Natera Inc., GeneDx Inc., GENEWIZ Inc., Novogene Corporation, PerkinElmer Inc., Personalis Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report
Which Region Is Forecasted To Lead The Whole Exome Sequencing Market In The Coming Years?
North America was the largest region in the whole exome sequencing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=10669&type=smp
Browse Through More Reports Similar to the Global Whole Exome Sequencing Market 2025, By The Business Research Company
Rna Analysis Transcriptomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
Antisense And Rnai Therapeutics Global Market Report 2025
Next Generation Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model